netFormulary
 Report : A-Z CDF items in Formulary 09/07/2020 02:46:25
[Back]
 
Section Status CDF Name
08.01.05 Formulary Cancer Drugs Fund Aflibercept Zaltrap
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Non Formulary Cancer Drugs Fund Cabozantinib Cometriq
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori
08.01.05 Non Formulary Cancer Drugs Fund Dabrafenib Tafinlar
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
02.01.01 Non Formulary Cancer Drugs Fund Digitoxin 
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven
08.01.05 Formulary Cancer Drugs Fund Everolimus Afinitor
08.03.04.01 Restricted Use Cancer Drugs Fund Fulvestrant Faslodex
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica
08.01.05 Non Formulary Cancer Drugs Fund Ipilimumab Yervoy
08.01.05 Restricted Use Cancer Drugs Fund Larotrectinib Vitrakvi
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance
08.02.04 Formulary Cancer Drugs Fund Nivolumab Opdivo
08.02.04 Non Formulary Cancer Drugs Fund Olaparib Lynparza
08.03.04.01 Restricted Use Cancer Drugs Fund Palbociclib Ibrance
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig
08.03.04.02 Non Formulary Cancer Drugs Fund Radium-223 dichloride 
08.01.05 Non Formulary Cancer Drugs Fund Regorafenib Stivarga
08.03.04.01 Formulary Cancer Drugs Fund Ribociclib Kisqali®
08.01.05 Restricted Use Cancer Drugs Fund Rucaparib Rubraca
08.01.05 Non Formulary Cancer Drugs Fund Sorafenib Nexavar
08.01.05 Non Formulary Cancer Drugs Fund Sunitinib Sutent
08.01.05 Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Non Formulary Cancer Drugs Fund Trametinib Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto
08.01.05 Non Formulary Cancer Drugs Fund Vismodegib Erivedge
Calderdale and Huddersfield